Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keck Medicine of Usc Buena Park
Buena Park, California, United States
Jason C. YeRecruiting - Recruiting
- Recruiting
- Recruiting
- Los Angeles General Medical Center
Los Angeles, California, United States
Jason C. YeRecruiting - Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
Jason C. YeRecruiting - Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
Jason C. YeRecruiting - University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
Surbhi SinghalRecruiting - Recruiting
- Recruiting
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
Richa DawarRecruiting - Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
Richa DawarRecruiting - Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
Tithi BiswasRecruiting - Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
Richa DawarRecruiting - University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Richa DawarRecruiting - Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
Richa DawarRecruiting - Recruiting
- Recruiting
- Recruiting
- Recruiting
- Jersey City Medical Center
Jersey City, New Jersey, United States
Salma K. JabbourRecruiting - Saint Barnabas Medical Center
Livingston, New Jersey, United States
Salma K. JabbourRecruiting - Monmouth Medical Center
Long Branch, New Jersey, United States
Salma K. JabbourRecruiting - Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Salma K. JabbourRecruiting - Newark Beth Israel Medical Center
Newark, New Jersey, United States
Salma K. JabbourRecruiting - Robert Wood Johnson University Hospital Somerset
Somerville, New Jersey, United States
Salma K. JabbourRecruiting - Community Medical Center
Toms River, New Jersey, United States
Salma K. JabbourRecruiting - Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
Active, not recruiting - Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
Active, not recruiting - Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Thomas W. LycanRecruiting - Recruiting
- Metrohealth Medical Center
Cleveland, Ohio, United States
Peter XieRecruiting - University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
Liza C. VillaruzRecruiting - University of Texas Medical Branch
Galveston, Texas, United States
Suspended
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2022
- Primary completion
- 30 Jun 2027
- Completion
- 30 Jun 2027
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 42
- Registry id
- NCT05198830
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.